Idioma: Español
Referencias bibliográficas: 18
Paginas: 355-356
Archivo PDF: 147.66 Kb.

FRAGMENTO

El angiosarcoma es un tumor maligno de origen vascular sanguíneo y/o linfático. Representa 2% de los sarcomas de tejidos blandos, y un tercio de ellos ocurre en la piel. De acuerdo con su etiología, existen tres variantes de angiosarcoma cutáneo: el idiopático, el asociado a radioterapia y el asociado a linfederma crónico. Recientemente se ha demostrado un papel oncogénico con la amplificación del gen myc, que es una característica frecuente en los angiosarcomas que aparecen posradiación y en los asociados a linfedema crónico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Nagao, K., Suzuki, K. y Yasuda, T., “Cutaneous angiosarcoma of the buttock complicated by severe thrombocytopenia: a case report”, Molecular and Clinical Oncology, 2013, 1: 903-907.

2. Mitra, A., Ramnath, R., Nicholson, S. y Yung, A., “An erythematous nodule on the eyelid”, Clin Exp Dermatol, 2008, 33: 87-89.

3. Shon, W., Sukov, W., Jenkins, S. y Folpe, A., “myc amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study”, Modern Pathology, 2014, 27: 509-515.

4. Marcon, I., Collini, P., Casanova, M., Meazza, C. y Ferrari, A., “Cutaneous angiosarcoma in a patient with xeroderma pigmentosum”, Pediatr Hematol Oncol, 2004, 21: 23-26.

5. Mark, R., Poen, J., Tran, L., Fu, Y. y Juillard, J., “Angiosarcoma: a report of 67 patients and a review of the literature”, Cancer, 1996, 77 (11): 2400-2406.

6. Kim, J., Kim, B. y Kang, H., “A recurrent angiosarcoma isolated to the eyelid without the recurrence on the primary lesion of the forhead”, Ann Dermatol, 2014, 26 (2): 231-235.

7. Terada, T., “Fatal poorly differentiated angiosarcoma of the scal”, Int J Clin Exp Pathol, 2010, 3 (5): 541-544.

8. Freedman, A., “Angiosarcoma of the scalp: case report and literature review”, Canadian J Sur, 1987, 30 (3): 197-198.

9. Vogt, T., Brockmeyer, N., Kutzner, H. y Schofer, H., “Brief s1 guidelines- cutaneous angiosarcoma and kaposi sarcoma”, J Dtsch Dermatol Ges, 2013, 11 (3): 2-10.

10. Orchard, G.E., Zelger, B., Jones, E.W. y Jones, R.R., “An immunohistochemical assessment of 19 cases of cutaneous angiosarcoma”, Histopathology, 1996, 28 (3): 235-240.

11. Schborg, C., Mertens, F. y Rydhoim, A., “Cytogenetic analysis of four angiosarcoma from deep and superficial soft tissues”, Cancer Genet Cytogenet, 1998, 100: 52-56.

12. Guadagnolo, B.A., Zagars, G.K., Araujo, D., Ravi, V., Shellenberger, T.D. y Sturgis, E.M., “Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp”, Head and Neck, 2011, 33 (5): 661-667.

13. Maddox, J.C. y Evans, H., “Angiosarcoma of skin and soft tissue: a study of forty-four cases”, Cancer, 1981, 48 (8): 1907-1921.

14. Fujisawa, Y., Yoshino, K., Kadono, T., Miyagawa, T., Nakamura, Y. y Fujimoto, M., “Chemoradiotherapy with taxane was superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: multi-center, retrospective study”, Br J Dermatol, 2014, 171: 1493-1500.

15. Stacchiotti, S., Palassini, E. y Sanfilippo, R., “Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian rare cancer network”, Ann Oncol, 2012, 23: 501-508.

16. Kajihara, I., Kanemaru, H. y Miyake, T., “Combination chemotherapy with s-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel”, Drug Discover Therapeutics, 2015, 9 (1) :75-77.

17. Rosen, A., Thimon, S., Ternant, D., Machet, M.C., Paintaud, G. y Machet, L., “Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face”, Br J Dermatol, 2010, 163: 225-227.

18. Ohgi, T., Imada, H. y Nomoto, S., “Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy”, Int H Radio Oncol Biol Phys, 2005, 61: 1446-1453.